![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Elicio Therapeutics, Inc., formerly Angion Biomedica Corp., is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of immunotherapies for the treatment of cancer and other diseases. It provides a platform, amphiphile (AMP) that delivers immuno therapeutics directl... Elicio Therapeutics, Inc., formerly Angion Biomedica Corp., is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of immunotherapies for the treatment of cancer and other diseases. It provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. The Company's lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). It is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). The Company is also evaluating the use of ELI-004, a universal AMP-modified clinical practice guidelines (CpG) adjuvant to treat or prevent additional diseases. The Company provides anaplastic lymphoma kinase (ALK) program to identify an internal development candidate. The Company conducts assessments for using ELI-004 to induce immune responses targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Show more
AIM 12 October 2017 NOTICE 12/10/2017 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM SPECIALIST INVESTMENT PROPERTIES PLC At the request of the company trading on AIM for the...
Specialist Investment PropertiesPLC 04 October 2017 4 October 2017 Specialist Investment Properties plc (the "Company" or "SIPP") Result of EGM Specialist Investment...
News) - Shares rose in Specialist Investment Properties PLC on Monday as it said it was seeking shareholder approval t ...
Specialist Investment PropertiesPLC 11 September 2017 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market...
Specialist Investment PropertiesPLC 11 September 2017 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market...
Specialist Investment PropertiesPLC 24 July 2017 24 July 2017 Specialist Investment Properties plc (the "Company" or "SIPP") Result of annual general meeting Specialist...
Specialist Investment PropertiesPLC 27 June 2017 27 June 2017 Specialist Investment Properties plc (the "Company" or "SIPP") Notice of annual general meeting and posting of...
News) - Shares in Specialist Investment Properties PLC dropped sharply on Friday as the company said it is considering ...
Specialist Investment PropertiesPLC 26 May 2017 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...
News) - Specialist Investment Properties PLC on Thursday said it has acquired a newly refurbished residential developm ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 0.443458980044 | 4.51 | 4.68 | 4.1999 | 13476 | 4.42933203 | CS |
4 | 0.24 | 5.59440559441 | 4.29 | 5.2 | 4.031 | 25043 | 4.65431639 | CS |
12 | -5.57 | -55.1485148515 | 10.1 | 10.1 | 3.3419 | 35810 | 5.51575178 | CS |
26 | 0.25 | 5.84112149533 | 4.28 | 11.45 | 3.3419 | 47347 | 6.8969783 | CS |
52 | -5.24 | -53.6335721597 | 9.77 | 11.45 | 2.96 | 52133 | 6.21902604 | CS |
156 | -9.47 | -67.6428571429 | 14 | 24.39 | 2.96 | 51954 | 7.48384869 | CS |
260 | -9.47 | -67.6428571429 | 14 | 24.39 | 2.96 | 51954 | 7.48384869 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions